Manufacturer

AstraZeneca GLP-1 medications

GLP-1 medications from AstraZeneca, with sourced prices, shortage reports and study results.

Last checked · Nov 16, 2026 UTC
1approved

Approved medicines

Alphabetical by active ingredient. Approved uses depend on the specific brand and formulation.

Exenatide

Byetta (discontinued), Bydureon BCise (discontinued), Generic exenatide

FDA-approved for

  • Type 2 diabetes

Subcutaneous injection · Twice daily (Byetta); once weekly (Bydureon BCise)

FDA shortage report (accessdata.fda.gov/scripts/drugshortages)

Published entry quote

~$422 per pen (goodrx.com/exenatide)

Generic exenatide (Amneal) · GoodRx

Checked on goodrx.com

Price conditions

GoodRx coupon, lowest listed price for one 5 mcg pen (60 doses: 30 days at the twice-daily dose)

Every exenatide product is now discontinued: the FDA withdrew the Byetta and Bydureon approvals in 2025, and Amneal's generic is listed by the FDA as discontinued too. Pharmacies may still dispense remaining stock.

Third-party reported price.

Checked . Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.